pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Vaccine · news · pharmadog
← back to Vaccine
News · Vaccine
688
stories
9h
STAT+: NIH to move last group of its research chimps to a sanctuary
stat
13h
White House pulls nomination for FDA nominee Overton
biopharma dive
14h
Pfizer leaps into ‘in vivo’ CAR-T with latest China deal
biopharma dive
15h
Merck scraps centerpiece of $2.7B ArQule buy after late-stage safety concerns
biospace
15h
STAT+: Pharmalittle: We’re reading about Overton FDA nomination being yanked, a Merck setback, and more
stat
15h
FDA publishes rejection letter for Summit drug; Nuvalent buyout pays more dividends for GSK
biopharma dive
21h
Pfizer enters in vivo CAR-T space via 3-program, $2.6B deal with China’s Starna
fiercebiotech
1d
White House yanks Overton nomination hours before committee vote
biospace
1d
Sellas claims Phase 3 win on AML cancer vaccine
endpoints
1d
U.S. loses measles elimination status, marking embarrassing stain on its public health record
stat
1d
AstraZeneca, Calidi, Tempest make significant workforce cuts
biospace
1d
STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and more
stat
1d
Sellas’ cancer vaccine slashes death risk by 41% in late-stage AML study
biospace
2d
STAT+: Newer GLP-1 drugs to combat obesity may be the next global battleground over access to medicines, expert warns
stat
2d
Sellas marks 9-month survival benefit in late-stage leukemia vaccine study
fiercebiotech
2d
STAT+: Pharmalittle: We’re reading about GLP-1 use, Covid-19 vaccine investment returns, and more
stat
2d
Democrats settle on a message: ‘Medicare for More’
stat
3d
Emerging biotech hubs step up as innovation economics evolve
biospace
5d
Moderna readies commercial cancer vaccine production ahead of FDA filing
endpoints
5d
The future of heart drug research in the wake of study setbacks
stat
5d
Senator-elect Abdul El-Sayed on restoring trust in science, the state of public health, and RFK Jr.
stat
6d
Blackstone bets $1.5B on Pfizer’s obesity drug
biopharma dive
6d
STAT+: Blackstone backs Pfizer’s bet on monthly obesity treatment
stat
6d
STAT+: What to know about Biogen’s big lupus study readout
stat
6d
STAT+: Alnylam, once in the hunt to be a $100 billion biotech, needs to solve its heart drug problem
stat
6d
Newly elected doctors and scientists hope to restore trust in science. It won’t be easy
stat
6d
Opinion: I research MAHA and Black Americans. The relationship is complicated — and fascinating
stat
7d
STAT+: Cassidy sets key vote on Overton, even as he remains undecided on nominee to lead FDA
stat
7d
AstraZeneca buys vaccine startup; FDA issues GLP-1 safety warning
biopharma dive
8d
AstraZeneca buys partner Omniose for bacterial vaccine technology
fiercebiotech
← prev
page 1 of 23
next →